StonvexLoading…
StonvexCore line items from UAMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $29.04M | $6.78M | $39.26M | $7.00M | $14.94M |
Operating Income | Not available | $-7.52M | $-8.46M | $357.99K | $-2.39M |
Net Income | Not available | $-11.29M | $-4.34M | $546.52K | $-1.73M |
EPS (Diluted) | $0.03 | $-0.08 | $-0.04 | $0.00 | $-0.02 |
Total Assets | Not available | $148.05M | $153.93M | $39.50M | $34.64M |
Total Liabilities | Not available | $16.15M | $12.97M | $6.91M | $6.04M |
Cash & Equivalents | Not available | $3.38M | $30.49M | $18.85M | $18.17M |
Free Cash Flow OCF − CapEx | Not available | $-24.64M | $-37.50M | $-2.59M | $1.79M |
Shares Outstanding | Not available | 143.74M | 140.04M | 116.11M | 112.95M |